Digital Edition: MedTech Strategist April 2023
Emerging cardiovascular companies are staking claims in pulsed field ablation and percutaneous ventricular assist devices. Biogen Digital Health identifies and validates digital biomarkers to accelerate neuroscience drug development; we look at their program to personalize multiple sclerosis care. Also in this issue, part 2 of our feature on Fogarty Innovation and profiles of start-ups Hyfe and Neuro One.
Read Article